Dr. Edo Kaluski, MD

Dr. Kaluski practices at Guthrie Robert Packer Hospital in Sayre, Pennsylvania, part of The Guthrie Clinic.

Dr. Kaluski's NPI, 1245321249, was assigned on September 27, 2006. Dr. Kaluski graduated from Ben Gurion University of the Negev in 1984. Dr. Kaluski holds Pennsylvania license MD446568.

Dr. Kaluski's primary practice is Guthrie Robert Packer Hospital, at One Guthrie Square, Sayre, PA 18840 in Bradford County. The practice phone is (570) 888-6666. Dr. Kaluski also practices at Guthrie Robert Packer Hospital, 1 Guthrie Sq, Sayre, PA 18840.

Dr. Kaluski's primary practice is Guthrie Robert Packer Hospital in Sayre, Pennsylvania, part of The Guthrie Clinic. Dr. Kaluski is also affiliated with Guthrie Lourdes Hospital. The medical group on file is Guthrie Medical Group. Dmand AI also links Dr. Kaluski to 3 more hospitals and 1 breast imaging center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kaluski practices, 6 sites in all. Vendor and product names are available with a free account.

Interventional cardiology is Dr. Kaluski's primary specialty in the NPI Registry, under taxonomy code 207RI0011X. Dr. Kaluski is licensed in Pennsylvania.

CMS data shows 2,437 Medicare services from Dr. Kaluski across 19 procedure codes in 2024, for 1,522 Medicare patients. Medicare paid $95,255 for them.

CMS counts 1,522 Medicare patients who saw Dr. Kaluski in 2024. The largest group is 75 to 84, with 564 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 18% are also on Medicaid. Their average risk score is 1.47, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Kaluski's median patient age at 74, with 47% women.

In 2024, Dr. Kaluski wrote 3,075 Medicare Part D claims for 472 patients. 82% of them were for generic drugs. CMS names the drug for 2,944 of them, across 40 drugs with 11 or more claims each, at $580,075 in total drug cost. In 2023, CMS named 2,934 claims across 37 drugs.

Dr. Kaluski accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 69 procedures of coronary angioplasty and stenting by Dr. Kaluski, more than 91% of the clinicians it reports for that procedure.

Pacemaker insertion or repair: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 112 papers to Dr. Kaluski, published from 2006 to 2025. 2018 was the busiest year, with 12. The most frequent topics are Angioplasty, Balloon, Coronary, Randomized Controlled Trials as Topic and Myocardial Infarction. Dr. Kaluski has published most often in Cardiovasc Revasc Med. Dr. Kaluski's most frequent co-authors are Safi Khan, Hammad Ur Rahman, MD and Sudhakar Sattur, MD.

Dmand AI links Dr. Kaluski to 2 clinical trials. Conditions studied include Acute Coronary Syndrome, Ventricular Fibrillation and Death, Sudden, Cardiac.

CMS Open Payments shows 787 general payments to Dr. Kaluski from 36 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 67% of the total. Janssen Pharmaceuticals, Inc paid the most, $45,733.

Dr. Kaluski graduated from Ben Gurion University of the Negev in 1984.